FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

The Food and Drug Administration (FDA) authorized Novavax’s COVID vaccine for adults on Wednesday, offering a protein-based alternative to mRNA shots from other pharmaceutical companies.

The newly authorized vaccine is scheduled in two doses separated by 21 days.

 

FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

Taiwan Asks for Help in Possible War

Taiwan’s Foreign Minister called on Australia to deepen…
FDA Authorizes Novavax COVID Vaccine
FDA Authorizes Novavax COVID Vaccine

Advancing Human Fraternity

Human fraternity is the key to alleviate the troubles facing…